Voronoi: Material Management Matter: Voluntary Withdrawal of Phase 1/2 Clinical Trial Plan for VRN110755
AI reading
★★★★ Bearish · Material event
Voluntary Withdrawal of Phase 1/2 Clinical Trial Application to Health Canada
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Voronoi
- 09.18 ★★ [Amended] Material Management Matter: Application for Change in Phase 1/2 Clinical Trial Plan for VRN110755
- 09.14 ★★ [Amended] Material Management Matter: Approval of Change in Phase 1/2 Clinical Trial Plan for VRN110755
- 09.09 ★★ [Amended] Material Management Matter: Application for Change in Phase 1/2 Clinical Trial Plan for VRN110755
- 09.07 ★★ [Amended] Material Management Matter: Approval of Change in Phase 1/2 Clinical Trial Plan for VRN110755
- 08.31 ★★ Large Shareholding Report (General)
- 08.28 ★★ Large Shareholding Report (General)
For information only. Not investment advice.